http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#head http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#assertion http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#provenance http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#publicationInfo http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#assertion http://bio2rdf.org/drugbank:DB01186 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01186_DB08919 http://bio2rdf.org/drugbank:DB08919 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01186_DB08919 http://bio2rdf.org/drugbank_resource:DB01186_DB08919 http://purl.org/dc/terms/identifier drugbank_resource:DB01186_DB08919 http://bio2rdf.org/drugbank_resource:DB01186_DB08919 http://purl.org/dc/terms/title DDI between Pergolide and Zuclopenthixol acetate - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and pergolide, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. Pergolide, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if pergolide is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB01186_DB08919 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB01186_DB08919 http://www.w3.org/2000/01/rdf-schema#label DDI between Pergolide and Zuclopenthixol acetate - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and pergolide, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. Pergolide, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if pergolide is initiated, discontinued or dose changed. [drugbank_resource:DB01186_DB08919] http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#provenance http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#publicationInfo http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#signature.MCwCFHVStSNoFYFL http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#signature.MCwCFHVStSNoFYFL http://purl.org/nanopub/x/hasSignature MCwCFHVStSNoFYFLQqUKbakbTrfiDJ7cAhQOUd45p4lPrUnPS1F68pH5midSnw== http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#signature.MCwCFHVStSNoFYFL http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk http://purl.org/dc/terms/created 2018-03-30T11:13:12.571+02:00 http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk#signature.MCwCFHVStSNoFYFL http://bio2rdf.org/drugbank_resource:DB01186_DB08919_nanopub.RAeIHBEAcFqNsSf7ci39XGXcixhsvXM6PWAtgKqjFJylk http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234